期刊文献+

莫沙必利联合黛力新治疗老年人功能性消化不良的疗效观察 被引量:14

A clinical study on the effect of mosapride united deanxit to the elderly with functional dyspepsia
下载PDF
导出
摘要 目的观察莫沙必利联合黛力新对老年人功能性消化不良的疗效。方法选取近四年来笔者所在医院158例老年人功能性消化不良患者,随机分为两组。治疗组采用莫沙必利、黛力新联合治疗;对照组采用莫沙必利治疗。结果治疗组患者治愈率达43·91%,总有效率达75·91%,分别优于对照组的21·05%和48·17%(P<0·05)。结论 莫沙必利联合黛力新治疗老年人功能性消化不良有良好疗效。 Objective To view the clinical effect of mosapride combined with deanxit in treating the elderly with functional dyspepsia(FD).Methods Select the last four years 158 cases of elderly hospital patients with functional dyspepsia were randomly divided into two groups.Treatment group:mosapride treatment combined with deanxit;the control group: treated with mosapride.Results Cure rate in patients treated with 43.91 percent,the total effective rate was 75.91%, respectively,than the control group,21.05% and 48.17%(P0.05).Conclusion Mosapride combined with deanxit in treating the elderly with functional dyspepsia have a good effect.
作者 谭彬
出处 《中外医学研究》 2011年第20期110-111,共2页 CHINESE AND FOREIGN MEDICAL RESEARCH
关键词 莫沙必利 黛力新 功能性消化不良 Mosapride Deanxit Functional dyspepsia
  • 相关文献

参考文献5

二级参考文献15

  • 1陈思维,薛淑英,王敏伟.介绍一种简易实验性胃排空测定方法[J].中国药理学通报,1994,10(4):317-317. 被引量:14
  • 2林剑锋.多虑平在内科的临床应用[J].新医学,1996,27(6):322-323. 被引量:46
  • 3鲁永保.功能性消化不良药物治疗[J].临床荟萃,1996,11(1):6-7. 被引量:14
  • 4施新猷.动物实验的基本技术操作方法[A].见:施新猷主编.医学动物实验方法[C].北京:人民卫生出版社,1980.103-104.
  • 5Thomas AR, Chan LN, Bauman JL, Olopade CO. Prolongation of the QT interval related to cisapride-diltiazem interaction. Pharmacotherapy, 1998, 18: 381~385.
  • 6Mine Y, Yoshikawa T, Oku S, Nagai R, Yoshida N,Hosoki K. Comparison of effect of mosapride citrate and existing 5-HT4 receptor agonists on gastrointestinal motility in vivo and in vitro. J Pharmacol Exp Ther, 1997, 283:1000~1008.
  • 7Yoshida N, Omoya H, Oka M, Furukawa K, Ito T, Karasawa T. AS-4370, a novel gastrokinetic agent free of dopamine D2 receptor antagonist properties. Arch Int Pharmacodyn Ther, 1989, 300: 51~67.
  • 8Yoshida N. Pharmacological effects of the gastroprokinetic agent mosapride citrate. Nippon Yakurigaku Zasshi,1999, 113: 299~307.
  • 9Carlsson L, Amos GJ, Andersson B, Drews L, Duker G,Wadstedt G. Electrophysiological characterization of the prokinetic agents cisapride and mosapride in vivo and in vitro: implications for proarrhythmic potential? J Pharmacol Exp Ther, 1997, 282: 220~227.
  • 10Kii Y, Ito T. Effects of 5-HT4-receptor agonists, cisapride,mosapride citrate, and zacopride, on cardiac action potentials in guinea pig isolated papillary muscles. J Cardiovasc Pharmacol, 1997, 29: 670~675.

共引文献162

同被引文献150

引证文献14

二级引证文献163

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部